Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,387 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase III study of tri-modality combination therapy with induction docetaxel plus cisplatin and 5-fluorouracil versus definitive chemoradiotherapy for locally advanced unresectable squamous-cell carcinoma of the thoracic esophagus (JCOG1510: TRIANgLE).
Terada M, Hara H, Daiko H, Mizusawa J, Kadota T, Hori K, Ogawa H, Ogata T, Sakanaka K, Sakamoto T, Kato K, Kitagawa Y. Terada M, et al. Among authors: ogawa h. Jpn J Clin Oncol. 2019 Dec 18;49(11):1055-1060. doi: 10.1093/jjco/hyz112. Jpn J Clin Oncol. 2019. PMID: 31411696 Clinical Trial.
Phase II study of chemoselection with docetaxel plus cisplatin and 5-fluorouracil induction chemotherapy and subsequent conversion surgery for locally advanced unresectable oesophageal cancer.
Yokota T, Kato K, Hamamoto Y, Tsubosa Y, Ogawa H, Ito Y, Hara H, Ura T, Kojima T, Chin K, Hironaka S, Kii T, Kojima Y, Akutsu Y, Matsushita H, Kawakami K, Mori K, Nagai Y, Asami C, Kitagawa Y. Yokota T, et al. Among authors: ogawa h. Br J Cancer. 2016 Nov 22;115(11):1328-1334. doi: 10.1038/bjc.2016.350. Epub 2016 Nov 3. Br J Cancer. 2016. PMID: 27811857 Free PMC article. Clinical Trial.
A 3-Year Overall Survival Update From a Phase 2 Study of Chemoselection With DCF and Subsequent Conversion Surgery for Locally Advanced Unresectable Esophageal Cancer.
Yokota T, Kato K, Hamamoto Y, Tsubosa Y, Ogawa H, Ito Y, Hara H, Ura T, Kojima T, Chin K, Hironaka S, Kii T, Kojima Y, Akutsu Y, Matsushita H, Kawakami K, Mori K, Makiuchi T, Nagumo R, Kitagawa Y. Yokota T, et al. Among authors: ogawa h. Ann Surg Oncol. 2020 Feb;27(2):460-467. doi: 10.1245/s10434-019-07654-8. Epub 2019 Aug 2. Ann Surg Oncol. 2020. PMID: 31376034 Clinical Trial.
Efficacy and feasibility of induction chemotherapy with paclitaxel, carboplatin and cetuximab for locally advanced unresectable head and neck cancer patients ineligible for combination treatment with docetaxel, cisplatin, and 5-fluorouracil.
Shirasu H, Yokota T, Kawakami T, Hamauchi S, Onozawa Y, Ogawa H, Onoe T, Mori K, Onitsuka T. Shirasu H, et al. Among authors: ogawa h. Int J Clin Oncol. 2020 Nov;25(11):1914-1920. doi: 10.1007/s10147-020-01742-6. Epub 2020 Jul 9. Int J Clin Oncol. 2020. PMID: 32648132
Efficacy and feasibility of docetaxel, cisplatin, and 5-fluorouracil induction chemotherapy for locally advanced head and neck squamous cell carcinoma classified as clinical nodal stage N2c, N3, or N2b with supraclavicular lymph node metastases.
Izawa N, Onozawa Y, Hikosaka T, Hamauchi S, Tsushima T, Todaka A, Machida N, Haraguchi Y, Ogawa H, Nishimura T, Nakagawa M, Fuke T, Iida Y, Kamijo T, Onitsuka T, Boku N, Yasui H, Yokota T. Izawa N, et al. Among authors: ogawa h. Int J Clin Oncol. 2015 Jun;20(3):455-62. doi: 10.1007/s10147-014-0749-4. Epub 2014 Sep 25. Int J Clin Oncol. 2015. PMID: 25248339
Survival benefit of adding docetaxel, cisplatin, and 5-fluorouracil induction chemotherapy to concurrent chemoradiotherapy for locally advanced nasopharyngeal carcinoma with nodal Stage N2-3.
Kawahira M, Yokota T, Hamauchi S, Onozawa Y, Ogawa H, Onoe T, Kamijo T, Iida Y, Nishimura T, Onitsuka T, Yasui H. Kawahira M, et al. Among authors: ogawa h. Jpn J Clin Oncol. 2017 Aug 1;47(8):705-712. doi: 10.1093/jjco/hyx057. Jpn J Clin Oncol. 2017. PMID: 28431119
Safety and efficacy of concurrent carboplatin or cetuximab plus radiotherapy for locally advanced head and neck cancer patients ineligible for treatment with cisplatin.
Hamauchi S, Yokota T, Mizumachi T, Onozawa Y, Ogawa H, Onoe T, Kamijo T, Iida Y, Nishimura T, Onitsuka T, Yasui H, Homma A. Hamauchi S, et al. Among authors: ogawa h. Int J Clin Oncol. 2019 May;24(5):468-475. doi: 10.1007/s10147-018-01392-9. Epub 2019 Jan 17. Int J Clin Oncol. 2019. PMID: 30656463 Free article. Clinical Trial.
5,387 results